Status Summary

First reading, referred to Finance on 1.20.2020. Public hearing in the House Committee on Finance on 2.10.2020. (updated 3.13.2020)

Legislative Session



In Progress


Rep. Davis

The pharmaceutical warehouse distributor tax preferential rate shall close, and the new revenue shall be allocated to fund pretreatment and recovery support services essential to combating the opioid epidemic. The estimated amounts of this revenue shall be calculated quarterly. The Recovery Pathways Account is created, and shall contain all revenue from taxes collected. Expenditures from the account may be used only for non-Medicaid reimbursable services including pretreatment substance use disorder services and recovery support services.